本页面由Tiger Trade Technology Pte. Ltd.提供服务

Axsome Therapeutics, Inc.

207.15
+1.670.81%
盘后208.000.8500+0.41%19:55 EDT
成交量:37.89万
成交额:7,869.79万
市值:108.51亿
市盈率:-54.97
高:210.68
开:204.48
低:203.70
收:205.48
52周最高:260.19
52周最低:112.90
股本:5,238.08万
流通股本:4,383.14万
量比:0.64
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-3.7685
每股收益(LYR):-3.6821
净资产收益率:-245.10%
总资产收益率:-16.31%
市净率:130.25
市盈率(LYR):-56.26

数据加载中...

2026/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/15

重要事件披露

Form 8-K - Current report
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities